FRANKFURT (Reuters) – A study of side effects following vaccination with AstraZeneca’s anti-COVID-19 shot in Scotland found only an association with a largely harmless bleeding condition and no link ...
Robert G. Kramer sold nearly 90,000 shares of his stock in Emergent BioSolutions, knowing that large quantities of vaccine ...
The University of Oxford is set to begin a trial combining Covid-19 vaccines from AstraZeneca Plc and Pfizer Inc. that could enable greater flexibility in the use of scarce supplies globally. The ...
By Jonathan Stempel NEW YORK, Jan 15 (Reuters) - A former chief executive of Emergent BioSolutions was charged on Thursday ...
Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results